Undersøgelsen var imidlertid positiv for endepunktet primær progressionsfri overlevelse, både samlet og i hver delgruppe af lokalt avanceret sygdom.
However, the EPC study was positive for the primary progression free survival (PFS) endpoint, both overall and in the locally advanced subgroups.